{"record_type":"pith_number_record","schema_url":"https://pith.science/schemas/pith-number/v1.json","pith_number":"pith:2025:XO4AMBMLHKVP7CZ3ZJHG72VOGM","short_pith_number":"pith:XO4AMBML","schema_version":"1.0","canonical_sha256":"bbb806058b3aaaff8b3bca4e6feaae3338d6bff7da5e643304b32da87b226738","source":{"kind":"arxiv","id":"2501.08744","version":1},"attestation_state":"computed","paper":{"title":"Visualisation of multi-indication randomised control trial evidence to support decision-making in oncology: a case study on bevacizumab","license":"http://creativecommons.org/licenses/by/4.0/","headline":"","cross_cats":[],"primary_cat":"stat.AP","authors_text":"Anne Thomas, Elizabeth Smyth, Janharpreet Singh, Marta O Soares, Pedro Saramago, Richard Adams, Sofia Dias, Stephen Palmer, Sumayya Anwer, Sylwia Bujkiewicz","submitted_at":"2025-01-15T11:59:28Z","abstract_excerpt":"Background: Evidence maps have been used in healthcare to understand existing evidence and to support decision-making. In oncology they have been used to summarise evidence within a disease area but have not been used to compare evidence across different diseases. As an increasing number of oncology drugs are licensed for multiple indications, visualising the accumulation of evidence across all indications can help inform policy-makers, support evidence synthesis approaches, or to guide expert elicitation on appropriate cross-indication assumptions. Methods: The multi-indication oncology thera"},"verification_status":{"content_addressed":true,"pith_receipt":true,"author_attested":false,"weak_author_claims":0,"strong_author_claims":0,"externally_anchored":false,"storage_verified":false,"citation_signatures":0,"replication_records":0,"graph_snapshot":true,"references_resolved":false,"formal_links_present":false},"canonical_record":{"source":{"id":"2501.08744","kind":"arxiv","version":1},"metadata":{"license":"http://creativecommons.org/licenses/by/4.0/","primary_cat":"stat.AP","submitted_at":"2025-01-15T11:59:28Z","cross_cats_sorted":[],"title_canon_sha256":"7b1069a809b7559878e8eafa29c1f552d454b082fb69ecb88baed601fbb6c91a","abstract_canon_sha256":"eb920fbc7501342a927fa14bef5f628a415ad6534d0b4f90be65283af73c9f6c"},"schema_version":"1.0"},"receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-07-05T10:01:25.564657Z","signature_b64":"yBCp0dm1k2p1j0ZLalJwo3Vu7dVL5jGDvTgDnfoPCkdBP8XeTfsotAtn7b8AafRMH9o3Y17xltowK8srNqcEDw==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"bbb806058b3aaaff8b3bca4e6feaae3338d6bff7da5e643304b32da87b226738","last_reissued_at":"2026-07-05T10:01:25.564117Z","signature_status":"signed_v1","first_computed_at":"2026-07-05T10:01:25.564117Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"graph_snapshot":{"paper":{"title":"Visualisation of multi-indication randomised control trial evidence to support decision-making in oncology: a case study on bevacizumab","license":"http://creativecommons.org/licenses/by/4.0/","headline":"","cross_cats":[],"primary_cat":"stat.AP","authors_text":"Anne Thomas, Elizabeth Smyth, Janharpreet Singh, Marta O Soares, Pedro Saramago, Richard Adams, Sofia Dias, Stephen Palmer, Sumayya Anwer, Sylwia Bujkiewicz","submitted_at":"2025-01-15T11:59:28Z","abstract_excerpt":"Background: Evidence maps have been used in healthcare to understand existing evidence and to support decision-making. In oncology they have been used to summarise evidence within a disease area but have not been used to compare evidence across different diseases. As an increasing number of oncology drugs are licensed for multiple indications, visualising the accumulation of evidence across all indications can help inform policy-makers, support evidence synthesis approaches, or to guide expert elicitation on appropriate cross-indication assumptions. Methods: The multi-indication oncology thera"},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"2501.08744","kind":"arxiv","version":1},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"integrity":{"clean":true,"summary":{"advisory":0,"critical":0,"by_detector":{},"informational":0},"endpoint":"/pith/2501.08744/integrity.json","findings":[],"available":true,"detectors_run":[],"snapshot_sha256":"c28c3603d3b5d939e8dc4c7e95fa8dfce3d595e45f758748cecf8e644a296938"},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"aliases":[{"alias_kind":"arxiv","alias_value":"2501.08744","created_at":"2026-07-05T10:01:25.564181+00:00"},{"alias_kind":"arxiv_version","alias_value":"2501.08744v1","created_at":"2026-07-05T10:01:25.564181+00:00"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.2501.08744","created_at":"2026-07-05T10:01:25.564181+00:00"},{"alias_kind":"pith_short_12","alias_value":"XO4AMBMLHKVP","created_at":"2026-07-05T10:01:25.564181+00:00"},{"alias_kind":"pith_short_16","alias_value":"XO4AMBMLHKVP7CZ3","created_at":"2026-07-05T10:01:25.564181+00:00"},{"alias_kind":"pith_short_8","alias_value":"XO4AMBML","created_at":"2026-07-05T10:01:25.564181+00:00"}],"events":[],"event_summary":{},"paper_claims":[],"inbound_citations":{"count":0,"internal_anchor_count":0,"sample":[]},"formal_canon":{"evidence_count":0,"sample":[],"anchors":[]},"links":{"html":"https://pith.science/pith/XO4AMBMLHKVP7CZ3ZJHG72VOGM","json":"https://pith.science/pith/XO4AMBMLHKVP7CZ3ZJHG72VOGM.json","graph_json":"https://pith.science/api/pith-number/XO4AMBMLHKVP7CZ3ZJHG72VOGM/graph.json","events_json":"https://pith.science/api/pith-number/XO4AMBMLHKVP7CZ3ZJHG72VOGM/events.json","paper":"https://pith.science/paper/XO4AMBML"},"agent_actions":{"view_html":"https://pith.science/pith/XO4AMBMLHKVP7CZ3ZJHG72VOGM","download_json":"https://pith.science/pith/XO4AMBMLHKVP7CZ3ZJHG72VOGM.json","view_paper":"https://pith.science/paper/XO4AMBML","resolve_alias":"https://pith.science/api/pith-number/resolve?arxiv=2501.08744&json=true","fetch_graph":"https://pith.science/api/pith-number/XO4AMBMLHKVP7CZ3ZJHG72VOGM/graph.json","fetch_events":"https://pith.science/api/pith-number/XO4AMBMLHKVP7CZ3ZJHG72VOGM/events.json","actions":{"anchor_timestamp":"https://pith.science/pith/XO4AMBMLHKVP7CZ3ZJHG72VOGM/action/timestamp_anchor","attest_storage":"https://pith.science/pith/XO4AMBMLHKVP7CZ3ZJHG72VOGM/action/storage_attestation","attest_author":"https://pith.science/pith/XO4AMBMLHKVP7CZ3ZJHG72VOGM/action/author_attestation","sign_citation":"https://pith.science/pith/XO4AMBMLHKVP7CZ3ZJHG72VOGM/action/citation_signature","submit_replication":"https://pith.science/pith/XO4AMBMLHKVP7CZ3ZJHG72VOGM/action/replication_record"}},"created_at":"2026-07-05T10:01:25.564181+00:00","updated_at":"2026-07-05T10:01:25.564181+00:00"}